Taken together with our previous findings that nasal rifampicin has beneficial effects in model mice of AD, tau-associated FTD, and DLB, the present results suggest that rifampicin is a good candidate as a preventive medicine with a broad spectrum against neurodegenerative dementia. The gene discussed is MAPT; the disease is Alzheimer disease.